SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3824Well, at least we have managed to stay clear of the Euro.Icebrg3/16/2004
3823<i>Nigel, that sounds vaguely boorish on your part</i> Sorry about nigel bates3/16/2004
3822The sum of: <<I keep having to remind myself that there are about seven aquidditch3/16/2004
3821TaiGen Biotechnology Raises $38 Million in its First Closing of Series B Financiscaram(o)uche3/16/2004
3820SEK 322m rights issue in Medivir <i>I keep having to remind myself that nigel bates3/16/2004
3819De Novo Ventures Closes $250 Million Life Science Fund Monday March 15, 7:06 pm nigel bates3/16/2004
3818Raptiva(R) (Efalizumab) Receives Approval for Moderate-to-Severe Plaque Psoriasiscaram(o)uche3/16/2004
3817Global drug sales up 9 pct to almost $500 blm -IMS Monday March 15, 1:26 pm ET nigel bates3/15/2004
3816CHICAGO, March 15 (Reuters) - ARIAD Pharmaceuticals Inc. (ARIA - news) said on quidditch3/15/2004
3815Thanks Rick...eom Zetazeta19613/13/2004
3814pipe.... ramoplanin, targeted at VRE. that's about it, really. U.S. and Cscaram(o)uche3/12/2004
3813Genentech Sees 20 Pct Annual Profit Gains Friday March 12, 4:42 pm ET By Jed Sescaram(o)uche3/12/2004
3812Rick, thanks for the post explaining gemifloxacin...having taken care of my sharzeta19613/11/2004
3811Momenta Pharmaceuticals Files for Initial Public Offering Thursday March 11, 5:4scaram(o)uche3/11/2004
3810it implies, a huge maybe, that you'll see less sepsis than otherwise.... tscaram(o)uche3/11/2004
3809<i>Gemifloxacin inhibits cytokine secretion by lipopolysaccharide stimulatBiomaven3/11/2004
3808acute, hospital-acquired Gram-positives...... empiric, acute exacerbations of Cscaram(o)uche3/11/2004
3807FACTIVE...Rick what's your take on this antibiotic?...I don't follow thezeta19613/11/2004
3806BioRexis Completes $30 Million Series B Financing KING OF PRUSSIA, Pa., March 1nigel bates3/11/2004
3805FACTIVE, gemifloxacin mesylate, Tablets Receive Marketing Approval from Health Cscaram(o)uche3/11/2004
3804When there's too much paper out there? expect more.scaram(o)uche3/10/2004
3803>>SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- Discovery Partners Internatuck3/10/2004
3802Four years after Nasdaq peak, top stocks way down Wednesday March 10, 5:36 pm ETscaram(o)uche3/10/2004
3801Gad, I hope they don't do an erbitux.keokalani'nui3/10/2004
3800Merck Reviewing 50 Possible Licensing Deals Wednesday March 10, 1:54 pm ET By Hnigel bates3/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News